Poly Medicure accelerates expansion with new plants,  capexIllustrative image – not actual.

Poly Medicure is set to accelerate its expansion strategy with major investments in manufacturing and research to double its international business revenue by FY30.

The company has earmarked Rs 296 crore in capital expenditure during FY26 to build new production capacities and strengthen product development. As part of its innovation-driven growth strategy, Poly Medicure launched 35 new products in FY26 and is developing a pipeline of more than 50 advanced medical devices focused on high-margin segments such as cardiology, critical care and oncology. Two new manufacturing facilities currently under construction will support rising production demand while enhancing operational efficiency through backward integration and shifting high-volume manufacturing to India. Poly Medicure is targeting international business revenue of around ₹2,560 crore by FY30, supported by stronger export capabilities and an expanding global product portfolio.

The planned capacity additions and innovation pipeline are expected to strengthen the company’s long-term growth prospects while maintaining healthy operating margins and reinforcing its position in the global medical devices industry.

← All latest storiesBack to top →